Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to demonstrate the clinical utility of fixed-dose SC Desirudin
for the prophylaxis of thrombosis as an alternative to heparin-based anticoagulation.